SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 396 filers reported holding SEATTLE GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $6,588,000 | +55.9% | 40,084 | +9.3% | 0.02% | +38.5% |
| Q1 2020 | $4,226,000 | -65.2% | 36,659 | -65.5% | 0.01% | -56.7% |
| Q4 2019 | $12,129,000 | +150.9% | 106,189 | +66.9% | 0.03% | +114.3% |
| Q3 2019 | $4,835,000 | +50.6% | 63,617 | +37.2% | 0.01% | +55.6% |
| Q2 2019 | $3,210,000 | -25.9% | 46,374 | -21.6% | 0.01% | -25.0% |
| Q1 2019 | $4,334,000 | +97.6% | 59,181 | +50.7% | 0.01% | +100.0% |
| Q4 2018 | $2,193,000 | -2.9% | 39,279 | +34.1% | 0.01% | +20.0% |
| Q3 2018 | $2,258,000 | +116.7% | 29,283 | +47.2% | 0.01% | +150.0% |
| Q2 2018 | $1,042,000 | 0.0% | 19,900 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $1,042,000 | -64.2% | 19,900 | -63.4% | 0.00% | -80.0% |
| Q4 2017 | $2,911,000 | +18.7% | 54,400 | +18.1% | 0.01% | -9.1% |
| Q2 2017 | $2,453,000 | +4.2% | 46,064 | +3.3% | 0.01% | 0.0% |
| Q4 2016 | $2,354,000 | -46.8% | 44,600 | -46.3% | 0.01% | -45.0% |
| Q3 2016 | $4,428,000 | +44.9% | 83,100 | +9.8% | 0.02% | +17.6% |
| Q2 2016 | $3,055,000 | – | 75,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 57,170 | $10,013,000 | 5.39% |
| Boxer Capital, LLC | 400,000 | $70,056,000 | 2.25% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 110,153 | $19,292,000 | 1.10% |
| DCF Advisers, LLC | 13,300 | $2,329,000 | 0.96% |
| XTX MARKETS LLC | 2,418 | $423,000 | 0.87% |
| FAIRFIELD, BUSH & CO. | 15,035 | $2,633,000 | 0.77% |
| Parcion Private Wealth LLC | 4,520 | $792,000 | 0.10% |
| Gulf International Bank (UK) Ltd | 26,091 | $4,569,000 | 0.06% |
| Princeton Portfolio Strategies Group LLC | 1,500 | $263,000 | 0.05% |
| Redpoint Investment Management Pty Ltd | 2,392 | $419,000 | 0.04% |